GCTK Stock Catalyst: Glucotrack Completes Strategic Business Combination with Lōkahi Therapeutics

Jul 14, 2026 · 5:41pm ET

Lōkahi Therapeutics becomes the operating and controlling business of the combined company.

Max move

+87.2%

High of day $14.85

Sparker timei

5:41pm ET

GCTK · Jul 14, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Glucotrack, Inc. (Nasdaq: GCTK) has completed its strategic business combination with Lōkahi Therapeutics. The transaction is structured such that Lōkahi Therapeutics becomes the operating and controlling business of the combined company, leveraging Glucotrack’s public market platform to support long-term growth and access to capital.

The combination aims to enhance the company's capabilities in the healthcare sector, specifically within the medical devices industry.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time GCTK sparks.

Download Sniper App →

Catch the next GCTK-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →